In summary, it is our novel discovery that WDR5 is upregulated in bladder cancer, and promotes bladder cancer cell proliferation, self-renewal and chemoresistance via activating a series of oncogenes by H3K4me3. This evidence concerns the gene WDR5 and urinary bladder carcinoma.